- Apremilast-d5
-
- $0.00 / 5mg
-
2024-10-28
- CAS:1258597-47-5
- Min. Order:
- Purity:
- Supply Ability: 10g
- (S)-Apremilast D5
-
- $0.00 / 5mg
-
2023-05-27
- CAS:1258597-47-5
- Min. Order: 1mg
- Purity: 96%
- Supply Ability: 50 mg
|
| ApreMilast-d5 Basic information |
Product Name: | ApreMilast-d5 | Synonyms: | ApreMilast-d5;CC-10004 D5;[2H5]-(S)-Apremilast;[2H5]-Apremilast (Racemic);Apremilast Impurity 44(Apremilast Racemic);Apremilast-d;(S)-N-(2-(1-(3-(Ethoxy-d5)-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide;N-{2-[(1S)-1-{3-[(1,1,2,2,2-2H?)ethoxy]-4-methoxyphenyl}-2-methanesulfonylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide | CAS: | 1258597-47-5 | MF: | C22H24N2O7S | MW: | 460.5 | EINECS: | | Product Categories: | Aromatics, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals | Mol File: | 1258597-47-5.mol | |
| ApreMilast-d5 Chemical Properties |
storage temp. | Store at -20°C | solubility | Acetonitrile: soluble,Methanol: soluble | form | A solid | color | Off-white to light yellow |
| ApreMilast-d5 Usage And Synthesis |
Uses | As isotope labelled Apremilast , an oral phosphodiesterase 4 inhibitor, ApreMilast-d5 is used in the treatment of psoriatic arthritis. |
| ApreMilast-d5 Preparation Products And Raw materials |
|